Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Dare Bioscience Inc

DARE ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$0.93

▼ -32.12%

Market Cap $14.22M · Vol 754.80K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$14.22M

Micro Cap

Div Yield

N/A

EPS Growth

+25.00%

YoY

RSI (14)

32.11

Momentum

Beta

0.99

vs Market

52W High

$3.78

75.40% below

52W Low

$0.77

20.86% above

Volume

754.80K

Avg 71.84K

P/B

9.84

Price-to-book

ROE

N/A

Return on equity

Free Float

90.94%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Dare Bioscience Inc (DARE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DARE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-33.57%

-55.07%

-67.48%

-45.29%

YTD

-51.81%

-55.07%

-89.45%

-95.16%

Financials & Valuation

TTM · Annual

Total Revenue	$1.03M
Net Income	$-13,399,270.00
Revenue Growth (YoY)	N/A
Gross Margin	71.29%
Operating Margin	-1,315.51%
Net Profit Margin	-1,300.66%
ROE	N/A
ROA · ROIC	-49.10% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	20.94
P/B	9.84
P/FCF	N/A
EPS Growth	+25.00%
Outstanding Shares	15.29M

Technical Indicators

50-Day SMA	$1.74
200-Day SMA	$1.90
RSI (14)	32.11
Beta	0.99
52-Week High	$3.78
52-Week Low	$0.77

Volume Today	754.80K
Avg Daily Volume (30D)	71.84K
Relative Volume	10.51x
Volatility (10D)	197.72
Volatility (30D)	162.75
Free Float	90.94%

Analyst Consensus

BUY

Current Price $0.93

Mean Target $9.67

52W Low$0.77 52W High$3.78

Current

Target

$0.77 $3.78

Current Analyst target

+939.43% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001V0GDP9

ISINUS23666P2002

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.